Autologous T-Cell Transplantation and the Immunotherapy of Residual Disease in Breast Cancer: Pilot Study of Vaccine-Driven T-Cell Expansion in Patients Treated With Dose-Intensive Chemotherapy - Related Studies

Autologous T-Cell Transplantation and the Immunotherapy of Residual Disease in Breast Cancer: Pilot Study of Vaccine-Driven T-Cell Expansion in Patients Treated With Dose-Intensive Chemotherapy

This study has been completed.

Study NCT00001440. Last updated on March 3, 2008. Information provided by National Institutes of Health Clinical Center (CC)

Find Related Studies by Searching for the Conditions, Interventions, and Sponsors found in this study:


1	Conditions listed in this trial
		Breast Neoplasm
		Neoplasm Metastasis

2	Additional conditions recognized in this trial
		Breast Neoplasms
		Neoplasms

3	More general conditions related to this trial
		Breast Diseases
		Neoplasms by Site
		Neoplastic Processes
		Pathologic Processes
		Skin Diseases

4	Interventions listed in this trial
		Autologous T cells
		Interleukin-2

5	More general drug interventions related to this trial
		Analgesics
		Analgesics, Non-Narcotic
		Antineoplastic Agents
		Central Nervous System Agents
		Peripheral Nervous System Agents
		Pharmacologic Actions
		Physiological Effects of Drugs
		Sensory System Agents
		Therapeutic Uses

6	Sponsors listed in this trial
		National Cancer Institute (NCI)